Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Cerchione

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Frontiers in Oncology|March 8, 2021
Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging TreatmentsMassimo Offidani, Laura Corvatta, Sonia Morè, et al.
Frontiers in Oncology|April 17, 2024
Anemia in patients receiving anticancer treatments: focus on novel therapeutic approachesClaudia Bozzini, Fabiana Busti, Giacomo Marchi, et al.
Panminerva Medica|September 21, 2020
Post-transplant consolidation based on combination of lenalidomide and proteasome inhibitors in multiple myelomaAlessandra Romano, Marco Santoro, Concetta Conticello, et al.
Frontiers in Oncology|March 30, 2026
Correction: TP53-mutated myelodysplastic syndromes and acute myeloid leukemia: a comprehensive overview of targeted approachesShweta Deshpande, Wing Fai Li, Junmin Song, et al.
Panminerva Medica|September 21, 2020
Prevention of venous thromboembolic events occurring in myeloma patients treated with second-generation novel agentsMarco Santoro, Alessandra Romano, Salvatrice Mancuso, et al.
Frontiers in Oncology|March 11, 2026
TP53-mutated myelodysplastic syndromes and acute myeloid leukemia: a 3 comprehensive overview of targeted approachesShweta Deshpande, Wing Fai Li, Junmin Song, et al.
Cardiovascular & Hematological Disorders Drug Targets|July 6, 2017
Is Anticoagulation with Novel Oral Anticoagulants an Effective Treatment for Tuberculosis Patients not Achieving a Therapeutic Range with Vitamin K Antagonists? A Systematic ReviewMarco Fiore, Alberto Enrico Maraolo, Paolo Chiodini, et al.
Medical Sciences (Basel, Switzerland)|January 21, 2026
From Glucose Transport to Microbial Modulation: The Impact of Sodium Glucose Co-Transporter-2 Inhibitors on the Gut MicrobiotaMina Y George, Nada K Gamal, Kerolos Safwat, et al.
Medicine|September 3, 2020
Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment?: A case reportClaudio Cerchione, Davide Nappi, Gerardo Musuraca, et al.
Panminerva Medica|September 21, 2020
Chemotherapy-based regimens in multiple myeloma in 2020Massimo Gentile, Fortunato Morabito, Massimo Martino, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Frontiers in Oncology|March 8, 2021
Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging TreatmentsMassimo Offidani, Laura Corvatta, Sonia Morè, et al.
Frontiers in Oncology|April 17, 2024
Anemia in patients receiving anticancer treatments: focus on novel therapeutic approachesClaudia Bozzini, Fabiana Busti, Giacomo Marchi, et al.
Panminerva Medica|September 21, 2020
Post-transplant consolidation based on combination of lenalidomide and proteasome inhibitors in multiple myelomaAlessandra Romano, Marco Santoro, Concetta Conticello, et al.
Frontiers in Oncology|March 30, 2026
Correction: TP53-mutated myelodysplastic syndromes and acute myeloid leukemia: a comprehensive overview of targeted approachesShweta Deshpande, Wing Fai Li, Junmin Song, et al.
Panminerva Medica|September 21, 2020
Prevention of venous thromboembolic events occurring in myeloma patients treated with second-generation novel agentsMarco Santoro, Alessandra Romano, Salvatrice Mancuso, et al.
Frontiers in Oncology|March 11, 2026
TP53-mutated myelodysplastic syndromes and acute myeloid leukemia: a 3 comprehensive overview of targeted approachesShweta Deshpande, Wing Fai Li, Junmin Song, et al.
Cardiovascular & Hematological Disorders Drug Targets|July 6, 2017
Is Anticoagulation with Novel Oral Anticoagulants an Effective Treatment for Tuberculosis Patients not Achieving a Therapeutic Range with Vitamin K Antagonists? A Systematic ReviewMarco Fiore, Alberto Enrico Maraolo, Paolo Chiodini, et al.
Medical Sciences (Basel, Switzerland)|January 21, 2026
From Glucose Transport to Microbial Modulation: The Impact of Sodium Glucose Co-Transporter-2 Inhibitors on the Gut MicrobiotaMina Y George, Nada K Gamal, Kerolos Safwat, et al.
Medicine|September 3, 2020
Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment?: A case reportClaudio Cerchione, Davide Nappi, Gerardo Musuraca, et al.
Panminerva Medica|September 21, 2020
Chemotherapy-based regimens in multiple myeloma in 2020Massimo Gentile, Fortunato Morabito, Massimo Martino, et al.
Pageof 13